Tag: David Pernock
December 10, 2018
Genetics Outlook 2019: CRISPR Technology Advances
With 2018 coming to a close, here's a look at the biggest genetics trends of the year and what's in...
January 5, 2017
Genetics Outlook 2017: The Revolution Nears
You've heard it before ... but this time, it really does look like the gene therapy revolution is drawing near.
December 30, 2016
Top Trends for Genetics Stocks in 2017
What can you expect from genetics stocks in 2017? We touched base with those in the know to bring you... December 19, 2016
Fibrocell Announces Leadership Changes
Fibrocell Science today announced that John Maslowski has been appointed Chief Executive Officer (CEO) and Douglas Swirsky has been appointed... November 10, 2016
Fibrocell Appoints Alfred T. Lane, MD, Chief Medical Advisor
Fibrocell Science today announced the appointment of Alfred T. Lane, MD, as Chief Medical Advisor of Fibrocell.
September 8, 2016
Fibrocell Science Closes $18.1 Million Financing Deal
Fibrocell Science, a relatively small gene therapy company, just closed a huge financing deal: it received $18.1 million after selling... April 18, 2016